Skip to main content
. 2020 Jul 1;2020(7):CD002251. doi: 10.1002/14651858.CD002251.pub4

Sahoo 2012.

Study characteristics
Methods RCT
Participants 56 women
Inclusion criteria: ASA I, age 20‐40, elective LSCS
Exclusion criteria: contraindications to SAB, patient refusal, unstable haemodynamics, coagulopathy, history of hypersensitivity to ondansetron or local anaesthetic agents, hypertensive disorders of pregnancy, cardiovascular insufficiency, receiving selective serotonin reuptake inhibitors or migraine medications
Setting: India
Interventions Pretreatment with ondansetron versus placebo
Group 1: IV ondansetron 4 mg diluted in 10 mL of normal saline given over 1 min, 5 min before spinal anaesthesia
Group 2: 10 mL of normal saline IV given over 1 min, 5 min before spinal anaesthesia
Outcomes Maternal: hypotension, decrease in BP, decrease in heart rate, nausea and vomiting
Neonatal: none
Notes Hypotension: SBP < 90 mmHg or DBP < 60 mmHg
Bradycardia: heart rate < 50 bpm
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomisation chart
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Not reported
Blinding of outcome assessment (detection bias)
All outcomes Low risk Blinded anaesthetist assessing outcomes
Incomplete outcome data (attrition bias)
All outcomes Low risk Not apparent
Selective reporting (reporting bias) Low risk Not apparent
Other bias Low risk Not apparent